Utang jangka cendhak marang modal Cardio Diagnostics (CDIO)

Cardio Diagnostics (CDIO) focuses on developing AI systems for the epigenetic study of cardiac pathologies, implementing a subscription model for medical centers. This price chart featuring the 0.03 metric clearly illustrates the asset's dynamics amid fierce competition with tech giants and startups. Stability is driven by the development of genetic blood tests and the expansion of partnerships with insurance organizations and employers in the US.

CDIO - Utang jangka cendhak marang modal cardiodiagnosticsinc.com ing rentang 28.04.2023 - 28.10.2026

Rincian analitis perusahaan Cardio Diagnostics Holdings, Inc. (CDIO)

- rega lan prakiraan konsensus rega:

Rega saham Cardio Diagnostics|CDIO - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Kapitalisasi pasar Cardio Diagnostics Holdings Inc.|CDIO - Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham Cardio Diagnostics|CDIO - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku cardiodiagnosticsinc.com|CDIO - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal Cardio Diagnostics|CDIO - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Cardio Diagnostics|CDIO - Utang perusahaan|Utang marang nilai buku Cardio Diagnostics Holdings Inc.

Analisis fundamental perusahaan:Cardio Diagnostics Holdings (CDIO)

This ratio determines the company's dependence on short-term liabilities relative to its equity, while the historical trend of short-term debt to equity allows for an assessment of liquidity risk and working capital management efficiency. A decrease in this metric minimizes the probability of a cash gap, which is critically important for Cardio Diagnostics (CDIO) as it scales PrecisionCHD tests and expands insurance coverage in the US.

Perusahaan pesaing